The preclinical phase of PsA: a challenge for the epidemiologist
- PMID: 28274910
- PMCID: PMC5554090
- DOI: 10.1136/annrheumdis-2017-211109
The preclinical phase of PsA: a challenge for the epidemiologist
Keywords: Epidemiology; Outcomes research; Psoriatic Arthritis.
Conflict of interest statement
Competing interests: AO has received support from an investigator-initiated research grant from Pfizer and has consulted for Novartis and Pfizer and has received payment for continuing medical education work related to psoriatic arthritis.
Figures
Comment on
-
Societal costs and patients' experience of health inequities before and after diagnosis of psoriatic arthritis: a Danish cohort study.Ann Rheum Dis. 2017 Sep;76(9):1495-1501. doi: 10.1136/annrheumdis-2016-210579. Epub 2017 Jan 30. Ann Rheum Dis. 2017. PMID: 28137915
References
-
- Ash ZR, Tinazzi I, Gallego CC, Kwok C, Wilson C, Goodfield M, et al. Psoriasis patients with nail disease have a greater magnitude of underlying systemic subclinical enthesopathythan those with normal nails. Ann Rheum Dis. 2012;71(4):553–6. - PubMed
-
- Offidani A, Cellini A, Valeri G, Giovagnoni A. Subclinical joint involvement in psoriasis: magnetic resonance imaging and X-ray findings. Acta Derm Venereol. 1998;78:463–5. - PubMed
-
- Faustini F, Simon D, Oliveira I, Kleyer A, Haschka J, Englbrecht M, et al. Subclinical joint inflammation in patients with psoriasis without concomitant psoriatic arthritis: a cross-sectional and longitudinal analysis. Ann Rheum Dis. 2016;75(12):2068–74. doi: 10.1136/annrheumdis-2015-208821. - DOI - PubMed
-
- McGonagle D, Ash Z, Dickie L, McDermott M, Aydin AZ. The early phase of psoriatic arthritis. Ann Rheum Dis. 2011;70(Suppl 1):i71–i6. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous
